REX AI Equity Premium Income ETF (AIPI) Stock Price Today
Aura AI Summary
Key Stats
- -Market Cap
- -Volume
- Income / Options OverlaySector
- $44.9352W High
- $32.4552W Low
- -Typical Hold Time
- -Enterprise Value
- -Div Yield
- -Trading Activity
Track REX AI Equity Premium Income ETF (AIPI) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, REX AI Equity Premium Income ETF has traded between a low of $32.45 and a high of $44.93, highlighting its annual price range. Buy and sell REX AI Equity Premium Income ETF shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About REX AI Equity Premium Income ETF
AIPI provides exposure to leading artificial intelligence firms while seeking to generate monthly income. It uses a covered call strategy to capture premiums from the volatility of AI-related stocks.
Most Recent News
Global AI in Medical Coding market to reach $10.6B by 2035 with 13.5% CAGR, driven by healthcare digital transformation.
The global AI in Medical Coding market, valued at $3 billion in 2025, is projected to grow to $10.6 billion by 2035 at a 13.5% CAGR. Growth is fueled by increasing adoption of AI technologies in healthcare for automated coding, fraud detection, and r...

EU approves RINVOQ as first systemic treatment for non-segmental vitiligo in patients 12+
The European Commission has approved RINVOQ (upadacitinib) for treating non-segmental vitiligo (NSV) in adults and adolescents aged 12 and older. This marks the first systemic medication authorized in the EU for NSV, the most common form of vitiligo,...

EU approves RINVOQ for severe alopecia areata, showing significant hair regrowth in patients.
The European Commission has approved RINVOQ (upadacitinib) for treating severe alopecia areata in adults and adolescents 12 years and older, based on Phase 3 clinical trials demonstrating significant scalp hair regrowth and improvements in eyebrows a...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.